Novartis – science based innovation for better patient outcomes

Primary tabs

Novartis – science based innovation for better patient outcomes

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Content from this campaign

Novartis Joins Global Initiative to Fight the Rise of Noncommunicable Diseases
January 18, 2016 /3BL Media/ - On January 18, 2017 at the World Economic Forum in Davos, Switzerland, Novartis joins more than 20 leading biopharmaceutical companies to launch “Access Accelerated”, a global initiative to further advance access to prevention and care for noncommunicable diseases (NCDs) in low and lower-middle income countries (LICs and LMICs). Chronic conditions such as...
Jan 18, 2017 8:00 AM ET
Novartis Wins Two Prestigious Prix Galien Foundation Awards
Basel, November 2, 2016 /3BL Media/ – Novartis has been awarded the prestigious 2016 Prix Galien USA Award for Best Biotechnology Product for Cosentyx® (secukinumab), as well as the Prix Galien Foundation “Discovery of the Decade” Award for Best Pharmaceutical Product for the drug Gleevec® (imatinib mesylate). The awards were presented at a ceremony in New York City. “We are honored to...
Nov 2, 2016 10:30 AM ET